FI94836C - Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut - Google Patents

Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut Download PDF

Info

Publication number
FI94836C
FI94836C FI870501A FI870501A FI94836C FI 94836 C FI94836 C FI 94836C FI 870501 A FI870501 A FI 870501A FI 870501 A FI870501 A FI 870501A FI 94836 C FI94836 C FI 94836C
Authority
FI
Finland
Prior art keywords
virus
cells
protein
recombinant
antigen
Prior art date
Application number
FI870501A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI870501A0 (fi
FI870501L (fi
FI94836B (fi
Inventor
Anthony F Purchio
Ingegerd Hellstroem
Joseph P Brown
Karl E Hellstroem
Gregory D Plowman
Sridhar Pennathur
Charles D Estin
Timothy M Rose
Shiu-Lok Hu
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26676698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI94836(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/007,230 external-priority patent/US5262177A/en
Application filed by Oncogen filed Critical Oncogen
Publication of FI870501A0 publication Critical patent/FI870501A0/fi
Publication of FI870501L publication Critical patent/FI870501L/fi
Application granted granted Critical
Publication of FI94836B publication Critical patent/FI94836B/fi
Publication of FI94836C publication Critical patent/FI94836C/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI870501A 1986-02-07 1987-02-06 Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut FI94836C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US82731386A 1986-02-07 1986-02-07
US82731386 1986-02-07
US723087 1987-01-27
US07/007,230 US5262177A (en) 1986-02-07 1987-01-27 Recombinant viruses encoding the human melanoma-associated antigen

Publications (4)

Publication Number Publication Date
FI870501A0 FI870501A0 (fi) 1987-02-06
FI870501L FI870501L (fi) 1987-08-08
FI94836B FI94836B (fi) 1995-07-31
FI94836C true FI94836C (fi) 1995-11-10

Family

ID=26676698

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870501A FI94836C (fi) 1986-02-07 1987-02-06 Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut

Country Status (18)

Country Link
JP (3) JP2664673B2 (da)
BE (1) BE1000175A3 (da)
CH (1) CH675424A5 (da)
DE (1) DE3703702C2 (da)
DK (1) DK63287A (da)
ES (2) ES2012815A6 (da)
FI (1) FI94836C (da)
GR (1) GR870195B (da)
HU (1) HU209144B (da)
IE (1) IE59597B1 (da)
IT (1) IT1222359B (da)
MX (1) MX9203574A (da)
NL (1) NL8700285A (da)
NO (1) NO178931C (da)
NZ (1) NZ219192A (da)
OA (1) OA08478A (da)
PT (1) PT84255B (da)
SE (2) SE506024C2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821925A1 (de) * 1998-05-15 1999-11-18 Roehnisch Tim Verfahren zur Herstellung einer Zusammensetzung zur Induktion einer tumorspezifischen Immunantwort, sowie Verwendung der Zusammensetzung zur Behandlung von Neoplasien
JP4414023B2 (ja) * 1999-08-05 2010-02-10 オリエンタル酵母工業株式会社 関節炎関連メラノトランスフェリンの測定方法および試薬
JP4708027B2 (ja) * 2002-10-01 2011-06-22 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 抗癌組成物および抗感染疾患組成物ならびにこれらを使用する方法
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer

Also Published As

Publication number Publication date
PT84255A (en) 1987-03-01
CH675424A5 (en) 1990-09-28
DK63287A (da) 1987-08-08
MX9203574A (es) 1992-07-01
BE1000175A3 (fr) 1988-07-12
ES2017258A6 (es) 1991-01-16
DE3703702C2 (de) 1997-07-10
SE8700466L (sv) 1987-08-08
NO870475L (no) 1987-08-10
JPH08280390A (ja) 1996-10-29
GR870195B (en) 1987-06-10
DE3703702A1 (de) 1988-02-18
NO870475D0 (no) 1987-02-06
JPH09135692A (ja) 1997-05-27
IE59597B1 (en) 1994-03-09
HU209144B (en) 1994-03-28
JPS62294698A (ja) 1987-12-22
PT84255B (pt) 1989-11-30
SE506024C2 (sv) 1997-11-03
NL8700285A (nl) 1987-09-01
FI870501A0 (fi) 1987-02-06
DK63287D0 (da) 1987-02-06
IT1222359B (it) 1990-09-05
IE870319L (en) 1987-08-07
SE8700466D0 (sv) 1987-02-06
JP2664673B2 (ja) 1997-10-15
IT8719291A0 (it) 1987-02-06
OA08478A (fr) 1988-07-29
NO178931C (no) 1996-07-03
NZ219192A (en) 1991-10-25
NO178931B (no) 1996-03-25
SE9202934D0 (sv) 1992-10-07
FI870501L (fi) 1987-08-08
HUT43107A (en) 1987-09-28
FI94836B (fi) 1995-07-31
ES2012815A6 (es) 1990-04-16

Similar Documents

Publication Publication Date Title
AU606046B2 (en) Vaccines against melanoma
US5141742A (en) Vaccines against melanoma
CA1341435C (en) Recombinant pox virus for immunization against tumor-associated antigens
JP3859695B2 (ja) Ｃ―ｅｒｂＢ―２外部ドメイン：ＧＰ７５
CN87100603A (zh) 抗黑素瘤疫苗
US6699475B1 (en) Recombinant pox virus for immunization against tumor-associated antigens
AU2021261945B2 (en) Compositions and methods for generating an immune response to a tumor associated antigen
WO1992005248A1 (en) Human papilloma viral protein expression for use in vaccine compositions
EP0474727A1 (en) Her2 extracellular domain.
JPH09173061A (ja) ベクターウイルスを用いた哺乳動物細胞、腫瘍特異的蛋白質、蛋白質の製造方法および薬用組成物
GB2188637A (en) Vaccines against melanoma
US7790170B2 (en) Modified leukotoxin protein
CA2426384A1 (en) Antibody inhibiting vplf activity
FI94836C (fi) Menetelmä melanoomaan liittyvän p97-antigeenin antigeenisen sukulaispeptidin tai -proteiinin valmistamiseksi, sekä siinä käyttökelpoiset yhdistelmävirukset, yhdistelmävektorit ja isäntäsolut
KR20060003903A (ko) 사람 암배아 항원을 암호화하는 합성 유전자 및 이의 용도
WO2011091716A1 (zh) 表皮生长因子受体变异体
JPH03155787A (ja) Ｅｂｚｄ蛋白質発現系
US8133873B2 (en) Recombinant chemokine-antigen vaccine
JPH03505327A (ja) プロカルシトニンペプチド
HK1102076B (en) Recombinant chemokine-antigen vaccine

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: ONCOGEN